Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2013-04-12)Premium Content

Biogen Idec Inc. (BIIB)

2013-05-17@18:13:31 ET
BRIEF: Biogen Idec awards $250G for genetics education (KRO)

2013-05-17@08:43:39 ET
Biogen Idec (BIIB) Showing Bullish Technicals But Could Break Through $232.38 Resistance (FBM)

2013-05-17@05:22:14 ET
Australia Patent: Biogen Idec MA, Puget Sound Blood Center File Application for 'Methods of reducing immunogenicity against Factor VIII therapy' (ABW)

2013-05-16@11:14:30 ET
Shares of Biogen Idec Under Pressure, Down 1.1% (F77)

2013-05-16@10:29:00 ET
Biogen Idec Foundation Awards $250,000 to East End House to Develop Genetics Education Program (BIZ)

2013-05-16@00:16:21 ET
FDA Receives Biogen Idec's Biologics License Application for Factor VIII Therapy for Hemophilia A (CLM)

2013-05-14@15:00:11 ET
Watch for Continued Gains in Shares of Biogen Idec (BIIB) (F71)

2013-05-14@10:04:22 ET
AVEO, Has Remained On Naked Short Lists 13 Consecutive Days (MTO)

2013-05-14@09:45:35 ET
Australia Patent: Biogen Idec International Neuroscience, University of Zurich File Application for 'Human anti-tau antibodies' (ABW)

2013-05-14@09:19:19 ET
Biogen Idec's BLA for first long-lasting Factor VIII therapy ELOCTATE for haemophilia A accepted by US FDA (MTO)

2013-05-13@11:02:56 ET
Biogen Idec Shares Climbing Higher, Up 2.4% (F77)

2013-05-13@09:43:32 ET
Biogen Idec (BIIB) Showing Bullish Technicals With Resistance At $216.21 (FBM)

2013-05-13@05:28:42 ET
Australia Patent: Biogen Idec MA Files Application for 'Methods of Treating Stroke' (ABW)